Jul 22, 2021 ProMIS Neurosciences to Present at 2021 Alzheimer’s Association International Conference
Jun 8, 2021 ProMIS Neurosciences congratulates Biogen on FDA accelerated approval of aducanumab for Alzheimer’s disease
May 27, 2021 ProMIS Neurosciences appoints renowned scientist, Dr. David Wishart as Chief Physics Officer
May 21, 2021 ProMIS Neurosciences re-initiates path to IND for PMN310 with producer cell line development
May 19, 2021 ProMIS Neurosciences appoints accomplished biotechnology executive, Neil Warma, to its Board of Directors